A flurry of recent studies demonstrates that gamma tocotrienol, a unique form of vitamin E, offers protection at the molecular level from a number of different types of cancer.

Prostate Cancer A study showed that gamma tocotrienol was able to kill prostate cancer cells by modulating gene signals, including reduction of the key pro-inflammatory gene signal, NF-kappaB. Additionally, it was found to modulate other genes that inhibited the ability of the prostate cancer cells to spread, meaning that in addition to killing prostate cancer cells it was able to reduce their invasiveness.

Stomach Cancer A study showed that gamma tocotrienol induced cell death and prevented cell metastasis of stomach cancer cells. The authors concluded, These findings suggest a potential mechanism of gamma-tocotrienol-mediated antitumor metastasis activity and indicate the role of vitamin E as potential chemopreventative agents against gastric cancer.

Colon Cancer A study showed that gamma tocotrienol could knock out colon cancer cells. Once again, part of the mechanism of action was a potent reduction of the inflammatory gene signal NF-kappaB.

Malignant Melanoma Skin cancer is a major concern for many. A new study shows that gamma tocotrienol can kill melanoma cells, primarily by reducing NF-kappaB and related gene signals. It also reduced gene signals associated with invasiveness. And it also helped chemo drugs work better, consistent with earlier findings of synergistic benefit.

While no person should consider any one vitamin a treatment or prevention of cancer, this data clearly shows that gamma tocotrienol is a powerful tool working in your favor.